Technical Analysis for CTMX - CytomX Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Lower Bollinger Band Walk | Weakness | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Stochastic Buy Signal | Bullish | -2.53% | |
Lower Bollinger Band Walk | Weakness | -2.53% | |
New 52 Week Low | Weakness | -2.53% | |
Lower Bollinger Band Touch | Weakness | -2.53% | |
Oversold Stochastic | Weakness | -2.53% | |
New 52 Week Closing Low | Bearish | 0.80% |
Alert | Time |
---|---|
Down 3% | about 18 hours ago |
Up 3% | about 18 hours ago |
Fell Below Lower Bollinger Band | about 18 hours ago |
Down 2 % | about 18 hours ago |
Down 1% | about 18 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/07/2024
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops novel class of antibody therapeutics based on its Probody technology platform that address clinically-validated cancer targets in immuno-oncology, such as PD-L1, as well as novel targets, comprising CD-166. In addition it has strategic collaborations with Bristol-Myers Squibb Company, Pfizer Inc., and ImmunoGen, Inc. to develop selected Probody therapeutics. The company was founded in 2008 and is headquartered in South San Francisco, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Life Sciences Compugen Monoclonal Antibody Therapy Immunogen Oncology Focused Biopharmaceutical
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Life Sciences Compugen Monoclonal Antibody Therapy Immunogen Oncology Focused Biopharmaceutical
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 5.85 |
52 Week Low | 0.833 |
Average Volume | 865,156 |
200-Day Moving Average | 1.59 |
50-Day Moving Average | 1.10 |
20-Day Moving Average | 0.99 |
10-Day Moving Average | 0.97 |
Average True Range | 0.07 |
RSI (14) | 31.97 |
ADX | 19.96 |
+DI | 13.11 |
-DI | 26.84 |
Chandelier Exit (Long, 3 ATRs) | 0.95 |
Chandelier Exit (Short, 3 ATRs) | 1.04 |
Upper Bollinger Bands | 1.12 |
Lower Bollinger Band | 0.87 |
Percent B (%b) | 0.0 |
BandWidth | 24.81 |
MACD Line | -0.06 |
MACD Signal Line | -0.04 |
MACD Histogram | -0.0122 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.97 | ||||
Resistance 3 (R3) | 0.98 | 0.95 | 0.96 | ||
Resistance 2 (R2) | 0.95 | 0.92 | 0.95 | 0.95 | |
Resistance 1 (R1) | 0.91 | 0.91 | 0.90 | 0.90 | 0.94 |
Pivot Point | 0.88 | 0.88 | 0.87 | 0.88 | 0.88 |
Support 1 (S1) | 0.84 | 0.85 | 0.83 | 0.84 | 0.80 |
Support 2 (S2) | 0.81 | 0.84 | 0.81 | 0.79 | |
Support 3 (S3) | 0.77 | 0.81 | 0.78 | ||
Support 4 (S4) | 0.77 |